Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Fellowship - Priority Announcement - Inflammatory Bowel Disease

University of Toronto

$45,000.00

Understanding how host genes influence the intestinal microbial composition and function in healthy first degree relatives of Crohn's disease subjects

EF 2013-14

Résumé
The microbial population in the human gut (the gut microbiome) is involved in normal function of the gut, as well as in shaping and maintaining the normal function of the immune system. Although it is clear that balance between the gut microbiota and the immune system is critical to the prevention of inflammation of the gut, what role a person's genes may play in controlling this "homeostasis" is only now being appreciated. We have recently identified a variation in a specific gene, known to be responsible for protection against inflammatory bowel disease (IBD), and associated with differences in gut microbiome composition and function. What is not known is if other genetic factors could also alter the gut microbiome. We hypothesize that the composition and function of the gut microbiome is directly influenced by host genetic makeup. Our objective is to analyze the gut bacteria composition and function in healthy subjects who are first degree relatives of individuals who have IBD and hence are more likely to carry the genes associated with the risk of developing disease. We have access to a large cohort of healthy first degree relatives being recruited as part of the CCFC GEM Project. First objective of this study will be to analyze the types of bacterial found in the stool samples of 2100 subjects in this population and determine if any differences are correlated with the gene variations found in the subjects. The second objective will be to determine if any differences in microbial function, both in terms of the bacterial genes and the bacterial products, are correlated with the genotype of the subjects. The relationships between the host genes and gut bacteria are key to the maintenance of health and alterations may well be at the root of the cause of disease. This study will allow for the identification of gene microbe pathways that can serve as targets for novel drug therapy to prevent the development of IBD in at-risk populations.
Programme
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
302347
Name
Turpin Williams
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario); Ferring Pharmaceuticals Inc. (North York, Ont.)
Instname2
Genetics
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Fellowships - Post-PhD
Projecttitle
Understanding how host genes influence the intestinal microbial composition and function in healthy first degree relatives of Crohn's disease subjects
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$45,000
Cihrequipment2
$0
Programname2
Fellowship - Priority Announcement - Inflammatory Bowel Disease
Keyworddelim
Bioinformatic; Biostatisticas; Crohn'S Disease; Genotype; Human Health; Inflammatory Bowel Disease; Microbiome; Quantitative Insights Into Microbial Ecology (Qiime); Sequencing; Single Nucleotide Polymorphism (Snp)
Abstract
The microbial population in the human gut (the gut microbiome) is involved in normal function of the gut, as well as in shaping and maintaining the normal function of the immune system. Although it is clear that balance between the gut microbiota and the immune system is critical to the prevention of inflammation of the gut, what role a person's genes may play in controlling this "homeostasis" is only now being appreciated. We have recently identified a variation in a specific gene, known to be responsible for protection against inflammatory bowel disease (IBD), and associated with differences in gut microbiome composition and function. What is not known is if other genetic factors could also alter the gut microbiome. We hypothesize that the composition and function of the gut microbiome is directly influenced by host genetic makeup. Our objective is to analyze the gut bacteria composition and function in healthy subjects who are first degree relatives of individuals who have IBD and hence are more likely to carry the genes associated with the risk of developing disease. We have access to a large cohort of healthy first degree relatives being recruited as part of the CCFC GEM Project. First objective of this study will be to analyze the types of bacterial found in the stool samples of 2100 subjects in this population and determine if any differences are correlated with the gene variations found in the subjects. The second objective will be to determine if any differences in microbial function, both in terms of the bacterial genes and the bacterial products, are correlated with the genotype of the subjects. The relationships between the host genes and gut bacteria are key to the maintenance of health and alterations may well be at the root of the cause of disease. This study will allow for the identification of gene microbe pathways that can serve as targets for novel drug therapy to prevent the development of IBD in at-risk populations.
Competitiondate
201311
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Turpin, Williams
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $45,000~ $0~